{"a":[{"_":"Xspray's Dasynoc approval bid foiled again by FDA's manufacturer concerns","$":{"href":"/pharma/xsprays-dasynoc-approval-bid-foiled-again-fdas-contract-manufacturer-concerns","hreflang":"en"}}]}
RegulatoryrejectedDasynocNegative
AI Analysis
Summary
Xspray Pharma's Dasynoc application for leukemia has been rejected by the FDA for the second time, with the regulator citing manufacturer concerns as the reason for the denial.
Outcome Details
FDA rejected resubmitted application due to manufacturer concerns
Importance:8/10
Sentiment:
-0.95
FDA rejectionregulatory setbackmanufacturing issuesleukemia
Related Companies
Read the original article
Published by FiercePharma on August 20, 2026 2:27 PM